Vinorelbine Tartrate

   
Google
 
Web NewDrugInformation.com

Vinorelbine Tartrate


Drug - Vinorelbine Tartrate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Vinorelbine Tartrate
Multiple ingredients are in alphabetical order.

Strength - EQ 10MG BASE/ML
The potency of the active ingredient(s), Vinorelbine Tartrate. May repeat for multiple part products.

Applicant - SICOR PHARMS
The firm name holding legal responsibility for Vinorelbine Tartrate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076028
The FDA assigned number to Vinorelbine Tartrate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vinorelbine Tartrate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 3, 2003
The date Vinorelbine Tartrate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Vinorelbine Tartrate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Vinorelbine Tartrate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sicor Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Vinorelbine Tartrate.

Vinorelbine Tartrate